Jusmiral Holdings sells significant stake in Cohance Lifesciences

Jusmiral Holdings Limited announced the sale of 34,148,000 shares in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) on September 18, 2025. This transaction, conducted via an open market sale, resulted in a post-sale holding of 21,99,30,170 shares, representing 57.49% of the total share/voting capital.

Before the sale, Jusmiral Holdings Limited, along with persons acting in concert (PAC) Berhyanda Limited and Berhyanda Midco Limited, collectively held 25,40,78,170 shares, amounting to 66.42% of the total share/voting capital. The sale reduced Jusmiral Holdings Limited's individual stake from 33.08% to 24.15% of the total share capital.

The proceeds from this sale are intended primarily for partial repayment of borrowings under a Notes Purchase Agreement, as previously disclosed on May 9, 2025. The total equity share capital of Cohance Lifesciences Limited remains 38,25,67,140 equity shares, with a face value of INR 1 each.